Feature CellMax developing first blood test for CRC preventative screening Padma Sundar, VP of Strategy and Market Access By Len Zehr Closely-held CellMax Life has developed FirstSightCRC, the first blood test to identify precancerous adenomas, with accuracy similar to colonoscopies, when... April 16, 2019